本文へ移動
cccskills

「concentration」の検索結果

66 件 ・ 関連度順

概要と使いどころ

meditate

無料

AI meta-cognitive meditation for observing reasoning patterns, clearing context noise, and developing single-pointed task focus. Maps shamatha to task concentration, vipassana to reasoning pattern observation, and distraction handling to scope-creep and assumption management. Use when transitioning between unrelated tasks, when reasoning feels scattered or jumpy, before a task requiring deep sustained attention, after a difficult interaction that may color subsequent work, or when reasoning feels biased by assumptions rather than evidence.

日本語の概要は準備中です。原文の説明を表示しています。

pjt222/agent-almanac372026年10月12日 更新

Portfolio Analyzer — sector allocation analysis vs SPY benchmark, geographic exposure, correlation matrix, concentration risk (HHI), beta-weighted portfolio delta, dividend/income analysis, and prioritized rebalancing recommendations. Triggered by "trade portfolio" or "analyze my portfolio".

日本語の概要は準備中です。原文の説明を表示しています。

zubair-trabzada/ai-trading-hermes322026年6月4日 更新

Use when a task needs the judgment of an Endoscopy Technician — deciding whether to release or quarantine a scope after a failed leak test or minimum-effective-concentration (MEC) reading, handling a point-of-use treatment delay against the manufacturer's reprocessing window, triaging a borescope finding on a working channel, or troubleshooting equipment and passing accessories during a live GI procedure.

日本語の概要は準備中です。原文の説明を表示しています。

wonsukchoi/domain-experts212026年10月12日 更新

Use when a task needs the judgment of a Dishwasher/kitchen steward — triaging a backed-up dish pit mid-rush, verifying sanitizer concentration or dish-machine rinse temperature against food-safety spec, deciding what routes to the three-compartment sink versus the dish machine, diagnosing a spike in breakage, or handling a machine failure mid-service.

日本語の概要は準備中です。原文の説明を表示しています。

wonsukchoi/domain-experts212026年10月12日 更新

Use when a task needs the judgment of a Credit Analyst — spreading financial statements and computing leverage/coverage ratios, writing a commercial credit memo, assigning or recommending an internal risk rating, structuring covenants on a term loan or revolver, or stress-testing a borrower's debt service under a downside case. Narrower than loan-officer (originates and manages the client relationship; the analyst underwrites the credit that officer brings in) and financial-risk-specialist (owns portfolio-level risk and concentration limits, not single-borrower underwriting).

日本語の概要は準備中です。原文の説明を表示しています。

wonsukchoi/domain-experts212026年10月12日 更新

Assess supply chain risk exposure and resilience posture. Analyzes supplier dependency mapping (Tier 1/2/3), geographic concentration risk, single-source vulnerability, disruption scenario modeling (pandemic, trade war, port closure), Monte Carlo simulation.

日本語の概要は準備中です。原文の説明を表示しています。

tinh2/skills-hub-registry202026年9月5日 更新

This skill determines whether confirmatory testing can be omitted after a positive aldosterone-to-renin ratio (ARR) in patients with suspected primary aldosteronism. It is applied when a patient exhibits spontaneous hypokalemia, undetectable renin, and a plasma aldosterone concentration ≥20 ng/dL (550 pmol/L).

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

Identifies young patients with classic primary aldosteronism features who may proceed directly to unilateral adrenalectomy without adrenal venous sampling based on high probability of unilateral disease. Triggered when a clinician sees a patient <35 years with hypokalemia, unilateral adrenal tumor on CT, and high plasma aldosterone concentration and asks whether AVS can be bypassed.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

Identifies patients with a positive aldosterone-to-renin ratio screening who may proceed directly to subtype testing without confirmatory testing based on specific clinical criteria. Triggers include spontaneous hypokalemia, baseline plasma aldosterone concentration >100 pg/mL (CLEIA), renin suppression, or a clinician questioning the need for a confirmatory test after a positive screen.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

Determines if primary aldosteronism is confirmed based on upright plasma aldosterone ≤6 ng/dL (170 nmol/L) on day 4 at 10 AM of fludrocortisone suppression test, provided plasma renin activity ≥1 ng/mL/h and plasma cortisol concentration lower than the 7 AM value to exclude ACTH confounding. Use when reviewing FST results to diagnose PA; triggers include "FST", "upright aldosterone ≤6 ng/dL", "PRA ≥1 ng/mL/h", and "cortisol drop".

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

In patients with primary aldosteronism receiving mineralocorticoid receptor antagonist therapy, the guideline recommends titrating the MRA dose upward to raise renin when blood pressure remains uncontrolled and renin is suppressed. Consider this step when hypertension is not at goal despite MRA therapy and plasma renin activity (or direct renin concentration) is low.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

Interprets the saline infusion test (SIT) to assess the probability of primary aldosteronism when a patient has a positive aldosterone-to-renin ratio (ARR) and requires confirmatory testing. Triggers include evaluating post‑infusion plasma aldosterone concentration (PAC) after a positive ARR, hypertension work‑up, or when deciding whether to proceed to adrenal venous sampling (AVS).

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

Recommends measurement of plasma ACTH to establish primary adrenal insufficiency (PAI) diagnosis in patients with confirmed cortisol deficiency; a plasma ACTH concentration ≥2-fold the upper limit of the reference range supports PAI. Use when evaluating plasma ACTH in a patient with low morning cortisol or abnormal corticotropin stimulation test.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

Busabase-backed App-in-Skill dashboard for a revenue-based-financing (RBF) fund or private-credit book of many small SME contracts. Use when the user invokes $kelly-portfolio-health or /kelly-portfolio-health, wants to check portfolio health, AUM, repayment progress, concentration risk, or a watchlist of contracts with declining revenue. Human actions (flag a contract for review, clear a flag, leave a note) write directly onto the contract's own Busabase record — this skill never moves money or changes contract terms. Generic and brand-free — not tied to any specific company or fund.

日本語の概要は準備中です。原文の説明を表示しています。

mr-kelly/skills52026年10月2日 更新

Enzyme kinetics — Michaelis-Menten Km, Vmax, kcat (turnover), and kcat/Km (catalytic efficiency / specificity constant) from substrate-velocity data, plus inhibition-mechanism analysis (competitive / uncompetitive / non-competitive, Ki). Fits the MM equation by nonlinear regression (and reports Lineweaver-Burk for reference). Use when you have substrate concentrations and initial reaction velocities and need kinetic parameters or to classify an inhibitor. NOT for BRENDA database lookups of published constants (use the BRENDA tools).

日本語の概要は準備中です。原文の説明を表示しています。

huang-sh/DeepScience42026年7月15日 更新

Designs and analyzes stable-isotope-resolved metabolomics (SIRM / isotope tracing / fluxomics) experiments that measure metabolic ACTIVITY via 13C/15N/2H tracers, distinct from steady-state pool profiling. Covers tracer choice, isotopologue vs isotopomer, mass-isotopomer distributions (MID), fractional enrichment, the mandatory natural-abundance + tracer-purity correction (IsoCor, AccuCor), and the metabolic/isotopic steady-state vs non-stationary (INST-MFA) distinction. Use when feeding a labeled tracer and interpreting labeling patterns, correcting raw isotopologue intensities, computing or plotting an MID, or deciding tracing vs abundance profiling. For absolute pool concentration and MRM mechanics see metabolomics/targeted-analysis; for constraint-based genome-scale flux (FBA, not empirical tracing) see systems-biology/flux-balance-analysis; for feature detection see metabolomics/xcms-preprocessing; for pathway enrichment that ignores the pool-vs-flux caveat see metabolomics/pathway-mapping.

日本語の概要は準備中です。原文の説明を表示しています。

huang-sh/DeepScience42026年7月15日 更新

Use this skill when the user asks about buying or selling a trucking company — valuation drivers (revenue, fleet age, CSA scores, customer concentration), asset purchase vs stock purchase, FMCSA authority transfer, due diligence checklist, common deal structures (cash, earnout, seller-financed), and what changes operationally after acquisition. Reference 49 CFR 365.401 (authority transfer).

日本語の概要は準備中です。原文の説明を表示しています。

x3allamerican/skills32026年5月17日 更新

Optimize fillet/notch geometry. Use when user mentions stress concentration, fillet optimization, reshaping surfaces, or reducing peak stress. Moves surfaces only.

日本語の概要は準備中です。原文の説明を表示しています。

MikeCheng1208/BattleTree22026年7月22日 更新